CTLA-4 Antibody-Drug Conjugate Reveals Autologous Destruction of B-Lymphocytes Associated with Regulatory T Cell Impairment

Researchers probed the decline of B cells in human CTLA-4 knock-in mice by using anti-human CTLA-4 antibody Ipilimumab conjugated to a drug payload emtansine